Skip to main content
Top
Published in: Orphanet Journal of Rare Diseases 1/2014

Open Access 01-12-2014 | Letter to the Editor

Expression of the SERPING1 gene is not regulated by promoter hypermethylation in peripheral blood mononuclear cells from patients with hereditary angioedema due to C1-inhibitor deficiency

Authors: Alberto López-Lera, Olga Pernia, Margarita López-Trascasa, Inmaculada Ibanez de Caceres

Published in: Orphanet Journal of Rare Diseases | Issue 1/2014

Login to get access

Abstract

SERPING1 mutations causing Hereditary Angioedema type I (HAE-I) due to C1-Inhibitor (C1-INH) deficiency display a dominant-negative effect usually resulting in protein levels far below the expected 50%. To further investigate mechanisms for its reduced expression, we analyzed the promoter DNA methylation status of SERPING1 and its influence on C1-INH expression. Global epigenetic reactivation correlated with C1-INH mRNA synthesis and protein secretion in Huh7 hepatoma cells. However, PBMCs extracted from controls, HAE-I and HAE-II patients presented identical methylation status of the SERPING1 promoter when analyzed by bisulphite sequencing; the proximal CpG island (exon 2) is constitutively unmethylated, while the most distant one (5.7Kb upstream the transcriptional start site) is fully methylated. These results correlate with the methylation profile observed in Huh7 cells and indicate that there is not a direct epigenetic regulation of C1-INH expression in PBMCs specific for each HAE type. Other indirect modes of epigenetic regulation cannot be excluded.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bowen T, Cicardi M, Farkas H, Bork K, Longhurst HJ, Zuraw B, Aygoeren-Pürsün E, Craig T, Binkley K, Hebert J, Ritchie B, Bouillet L, Betschel S, Cogar D, Dean J, Devaraj R, Hamed A, Kamra P, Keith PK, Lacuesta G, Leith E, Lyons H, Mace S, Mako B, Neurath D, Poon MC, Rivard GE, Schellenberg R, Rowan D, Rowe A, et al: 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin Immunol. 2010, 6 (1): 24-10.1186/1710-1492-6-24. doi:10.1186/1710-1492-6-24CrossRefPubMedPubMedCentral Bowen T, Cicardi M, Farkas H, Bork K, Longhurst HJ, Zuraw B, Aygoeren-Pürsün E, Craig T, Binkley K, Hebert J, Ritchie B, Bouillet L, Betschel S, Cogar D, Dean J, Devaraj R, Hamed A, Kamra P, Keith PK, Lacuesta G, Leith E, Lyons H, Mace S, Mako B, Neurath D, Poon MC, Rivard GE, Schellenberg R, Rowan D, Rowe A, et al: 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin Immunol. 2010, 6 (1): 24-10.1186/1710-1492-6-24. doi:10.1186/1710-1492-6-24CrossRefPubMedPubMedCentral
2.
go back to reference Caballero T, Farkas H, Bouillet L, Bowen T, Gompel A, Fagerberg C, Björkander J, Bork K, Bygum A, Cicardi M, de Carolis C, Frank M, Gooi JH, Longhurst H, Martínez-Saguer I, Nielsen EW, Obtulowitz K, Perricone R, Prior N: International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency. J Allergy Clin Immunol. 2012, 129 (2): 308-320. 10.1016/j.jaci.2011.11.025.CrossRefPubMed Caballero T, Farkas H, Bouillet L, Bowen T, Gompel A, Fagerberg C, Björkander J, Bork K, Bygum A, Cicardi M, de Carolis C, Frank M, Gooi JH, Longhurst H, Martínez-Saguer I, Nielsen EW, Obtulowitz K, Perricone R, Prior N: International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency. J Allergy Clin Immunol. 2012, 129 (2): 308-320. 10.1016/j.jaci.2011.11.025.CrossRefPubMed
3.
go back to reference Kramer J, Rosen FS, Colten HR, Rajczy K, Strunk RC: Transinhibition of C1 inhibitor synthesis in type I hereditary angioneurotic edema. J Clin Invest. 1993, 91 (3): 1258-1262. 10.1172/JCI116290.CrossRefPubMedPubMedCentral Kramer J, Rosen FS, Colten HR, Rajczy K, Strunk RC: Transinhibition of C1 inhibitor synthesis in type I hereditary angioneurotic edema. J Clin Invest. 1993, 91 (3): 1258-1262. 10.1172/JCI116290.CrossRefPubMedPubMedCentral
4.
go back to reference Pappalardo E, Zingale LC, Cicardi M: C1 inhibitor gene expression in patients with hereditary angioedema: quantitative evaluation by means of real-time RT-PCR. J Allergy Clin Immunol. 2004, 114 (3): 638-644. 10.1016/j.jaci.2004.06.021.CrossRefPubMed Pappalardo E, Zingale LC, Cicardi M: C1 inhibitor gene expression in patients with hereditary angioedema: quantitative evaluation by means of real-time RT-PCR. J Allergy Clin Immunol. 2004, 114 (3): 638-644. 10.1016/j.jaci.2004.06.021.CrossRefPubMed
5.
go back to reference Cugno M, Zanichelli A, Foieni F, Caccia S, Cicardi M: C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress. Trends Mol Med. 2009, 15 (2): 69-78. 10.1016/j.molmed.2008.12.001. doi:10.1016/j.molmed.2008.12.001CrossRefPubMed Cugno M, Zanichelli A, Foieni F, Caccia S, Cicardi M: C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progress. Trends Mol Med. 2009, 15 (2): 69-78. 10.1016/j.molmed.2008.12.001. doi:10.1016/j.molmed.2008.12.001CrossRefPubMed
6.
go back to reference Feinberg AP: Phenotypic plasticity and the epigenetics of human disease. Nature. 2007, 447 (7143): 433-440. 10.1038/nature05919.CrossRefPubMed Feinberg AP: Phenotypic plasticity and the epigenetics of human disease. Nature. 2007, 447 (7143): 433-440. 10.1038/nature05919.CrossRefPubMed
7.
go back to reference Toyota M, Suzuki H, Sasaki Y, Maruyama R, Imai K, Shinomura Y, Tokino T: Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res. 2008, 68: 4123-4132. 10.1158/0008-5472.CAN-08-0325.CrossRefPubMed Toyota M, Suzuki H, Sasaki Y, Maruyama R, Imai K, Shinomura Y, Tokino T: Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res. 2008, 68: 4123-4132. 10.1158/0008-5472.CAN-08-0325.CrossRefPubMed
8.
go back to reference Grady WM, Parkin RK, Mitchell PS, Lee JH, Kim YH, Tsuchiya KD, Washington MK, Paraskeva C, Willson JK, Kaz AM, Kroh EM, Allen A, Fritz BR, Markowitz SD, Tewari M: Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer. Oncogene. 2008, 27: 3880-3888. 10.1038/onc.2008.10.CrossRefPubMed Grady WM, Parkin RK, Mitchell PS, Lee JH, Kim YH, Tsuchiya KD, Washington MK, Paraskeva C, Willson JK, Kaz AM, Kroh EM, Allen A, Fritz BR, Markowitz SD, Tewari M: Epigenetic silencing of the intronic microRNA hsa-miR-342 and its host gene EVL in colorectal cancer. Oncogene. 2008, 27: 3880-3888. 10.1038/onc.2008.10.CrossRefPubMed
9.
go back to reference Chelbi ST, Mondon F, Jammes H, Buffat C, Mignot TM, Tost J, Busato F, Gut I, Rebourcet R, Laissue P, Tsatsaris V, Goffinet F, Rigourd V, Carbonne B, Ferré F, Vaiman D: Expressional and epigenetic alterations of placental serine protease inhibitors: SERPINA3 is a potential marker of preeclampsia. Hypertension. 2007, 49 (1): 76-83. 10.1161/01.HYP.0000250831.52876.cb. Epub 2006 Nov 6CrossRefPubMed Chelbi ST, Mondon F, Jammes H, Buffat C, Mignot TM, Tost J, Busato F, Gut I, Rebourcet R, Laissue P, Tsatsaris V, Goffinet F, Rigourd V, Carbonne B, Ferré F, Vaiman D: Expressional and epigenetic alterations of placental serine protease inhibitors: SERPINA3 is a potential marker of preeclampsia. Hypertension. 2007, 49 (1): 76-83. 10.1161/01.HYP.0000250831.52876.cb. Epub 2006 Nov 6CrossRefPubMed
10.
go back to reference Takai D, Jones PA: The CpG island searcher: a new WWW resource. In Silico Biol. 2003, 3 (3): 235-240.PubMed Takai D, Jones PA: The CpG island searcher: a new WWW resource. In Silico Biol. 2003, 3 (3): 235-240.PubMed
11.
go back to reference Lappin DF, Guc D, Hill A, McShane T, Whaley K: Effect of interferon-gamma on complement gene expression in different cell types. Biochem J. 1992, 281 (Pt 2): 437-442.CrossRefPubMedPubMedCentral Lappin DF, Guc D, Hill A, McShane T, Whaley K: Effect of interferon-gamma on complement gene expression in different cell types. Biochem J. 1992, 281 (Pt 2): 437-442.CrossRefPubMedPubMedCentral
12.
go back to reference Morris KM, Aden DP, Knowles BB, Colten HR: Complement biosynthesis by the human hepatoma-derived cell line HepG2. J Clin Invest. 1982, 70 (4): 906-913. 10.1172/JCI110687.CrossRefPubMedPubMedCentral Morris KM, Aden DP, Knowles BB, Colten HR: Complement biosynthesis by the human hepatoma-derived cell line HepG2. J Clin Invest. 1982, 70 (4): 906-913. 10.1172/JCI110687.CrossRefPubMedPubMedCentral
13.
go back to reference Ibanez de Caceres I, Dulaimi E, Hoffman AM, Al-Saleem T, Uzzo RG, Cairns P: Identification of novel target genes by an epigenetic reactivation screen of renal cancer. Cancer Res. 2006, 66 (10): 5021-5028. 10.1158/0008-5472.CAN-05-3365.CrossRefPubMed Ibanez de Caceres I, Dulaimi E, Hoffman AM, Al-Saleem T, Uzzo RG, Cairns P: Identification of novel target genes by an epigenetic reactivation screen of renal cancer. Cancer Res. 2006, 66 (10): 5021-5028. 10.1158/0008-5472.CAN-05-3365.CrossRefPubMed
14.
go back to reference de la Cruz RM, López-Lera A, López-Trascasa M: Analysis of SERPING1 expression on hereditary angioedema patients: quantitative analysis of full-length and exon 3 splicing variants. Immunol Lett. 2012, 141 (2): 158-164. 10.1016/j.imlet.2011.07.011. doi:10.1016/j.imlet.2011.07.011CrossRefPubMed de la Cruz RM, López-Lera A, López-Trascasa M: Analysis of SERPING1 expression on hereditary angioedema patients: quantitative analysis of full-length and exon 3 splicing variants. Immunol Lett. 2012, 141 (2): 158-164. 10.1016/j.imlet.2011.07.011. doi:10.1016/j.imlet.2011.07.011CrossRefPubMed
15.
go back to reference Aune TM, Collins PL, Collier SP, Henderson MA, Chang S: Epigenetic Activation and Silencing of the Gene that Encodes IFN-γ. Front Immunol. 2013, 4: 112-10.3389/fimmu.2013.00112. doi:10.3389/fimmu.2013.00112CrossRefPubMedPubMedCentral Aune TM, Collins PL, Collier SP, Henderson MA, Chang S: Epigenetic Activation and Silencing of the Gene that Encodes IFN-γ. Front Immunol. 2013, 4: 112-10.3389/fimmu.2013.00112. doi:10.3389/fimmu.2013.00112CrossRefPubMedPubMedCentral
16.
go back to reference Ibanez de Caceres I, Cortes-Sempere M, Moratilla C, Machado-Pinilla R, Rodriguez-Fanjul V, Manguán-García C, Cejas P, López-Ríos F, Paz-Ares L, de CastroCarpeño J, Nistal M, Belda-Iniesta C, Perona R: IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer. Oncogene. 2010, 29 (11): 1681-1690. 10.1038/onc.2009.454. doi:10.1038/onc.2009.454CrossRefPubMed Ibanez de Caceres I, Cortes-Sempere M, Moratilla C, Machado-Pinilla R, Rodriguez-Fanjul V, Manguán-García C, Cejas P, López-Ríos F, Paz-Ares L, de CastroCarpeño J, Nistal M, Belda-Iniesta C, Perona R: IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer. Oncogene. 2010, 29 (11): 1681-1690. 10.1038/onc.2009.454. doi:10.1038/onc.2009.454CrossRefPubMed
17.
go back to reference López-Lera A, Favier B, de la Cruz RM, Garrido S, Drouet C, López-Trascasa M: A new case of homozygous C1-inhibitor deficiency suggests a role for Arg378 in the control of kinin pathway activation. J Allergy Clin Immunol. 2010, 126 (6): 1307-10.e3. 10.1016/j.jaci.2010.07.037. doi:10.1016/j.jaci.2010.07.037CrossRefPubMed López-Lera A, Favier B, de la Cruz RM, Garrido S, Drouet C, López-Trascasa M: A new case of homozygous C1-inhibitor deficiency suggests a role for Arg378 in the control of kinin pathway activation. J Allergy Clin Immunol. 2010, 126 (6): 1307-10.e3. 10.1016/j.jaci.2010.07.037. doi:10.1016/j.jaci.2010.07.037CrossRefPubMed
18.
go back to reference Flicek P, Amode MR, Barrell D, Beal K, Billis K, Brent S, Carvalho-Silva D, Clapham P, Coates G, Fitzgerald S, Gil L, Girón CG, Gordon L, Hourlier T, Hunt S, Johnson N, Juettemann T, Kähäri AK, Keenan S, Kulesha E, Martin FJ, Maurel T, McLaren WM, Murphy DN, Nag R, Overduin B, Pignatelli M, Pritchard B, Pritchard E, Riat HS, et al: Ensembl 2014. Nucleic Acids Res. 2014, (Database issue): D749-D755. 10.1093/nar/gkt1196. doi:10.1093/nar/gkt1196CrossRef Flicek P, Amode MR, Barrell D, Beal K, Billis K, Brent S, Carvalho-Silva D, Clapham P, Coates G, Fitzgerald S, Gil L, Girón CG, Gordon L, Hourlier T, Hunt S, Johnson N, Juettemann T, Kähäri AK, Keenan S, Kulesha E, Martin FJ, Maurel T, McLaren WM, Murphy DN, Nag R, Overduin B, Pignatelli M, Pritchard B, Pritchard E, Riat HS, et al: Ensembl 2014. Nucleic Acids Res. 2014, (Database issue): D749-D755. 10.1093/nar/gkt1196. doi:10.1093/nar/gkt1196CrossRef
19.
go back to reference Agathanggelou A, Bièche I, Ahmed-Choudhury J, Nicke B, Dammann R, Baksh S, Gao B, Minna JD, Downward J, Maher ER, Latif F: Identification of novel gene expression targets for the Ras association domain family 1 (RASSF1A) tumor suppressor gene in non-small cell lung cancer and neuroblastoma. Cancer Res. 2003, 63 (17): 5344-5351.PubMedPubMedCentral Agathanggelou A, Bièche I, Ahmed-Choudhury J, Nicke B, Dammann R, Baksh S, Gao B, Minna JD, Downward J, Maher ER, Latif F: Identification of novel gene expression targets for the Ras association domain family 1 (RASSF1A) tumor suppressor gene in non-small cell lung cancer and neuroblastoma. Cancer Res. 2003, 63 (17): 5344-5351.PubMedPubMedCentral
Metadata
Title
Expression of the SERPING1 gene is not regulated by promoter hypermethylation in peripheral blood mononuclear cells from patients with hereditary angioedema due to C1-inhibitor deficiency
Authors
Alberto López-Lera
Olga Pernia
Margarita López-Trascasa
Inmaculada Ibanez de Caceres
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Orphanet Journal of Rare Diseases / Issue 1/2014
Electronic ISSN: 1750-1172
DOI
https://doi.org/10.1186/s13023-014-0103-y

Other articles of this Issue 1/2014

Orphanet Journal of Rare Diseases 1/2014 Go to the issue